Avivagen Inc. | Balance Sheet

Fiscal year is November-October. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,045.70
768.80
632.20
5,142.40
1,600.10
2,207.40
Total Accounts Receivable
214.60
49.00
37.50
40.70
99.00
226.90
Inventories
76.00
18.30
1.00
2.50
90.40
579
Other Current Assets
-
-
10.30
10.60
60.10
28.90
Total Current Assets
1,336.20
836.10
681.00
5,196.20
1,849.70
3,042.20
Net Property, Plant & Equipment
65.20
32.50
11.70
-
-
67
Intangible Assets
0.40
-
-
-
-
-
Total Assets
1,401.90
868.60
692.70
5,196.20
1,849.70
3,109.20
ST Debt & Current Portion LT Debt
-
-
-
148.20
103.70
Accounts Payable
318.80
107.20
242.50
151.40
241.10
Other Current Liabilities
55.20
50.70
37.60
328.90
259.10
Total Current Liabilities
373.90
157.90
280.00
628.50
603.90
Long-Term Debt
-
-
85.80
927.80
1,077.00
Other Liabilities
2,957.60
3,102.80
-
-
-
Total Liabilities
3,331.50
3,260.70
194.20
1,556.30
1,680.90
Common Equity (Total)
1,929.60
2,392.00
2,825.10
3,639.90
168.80
Total Shareholders' Equity
1,929.60
2,392.00
2,825.10
3,639.90
168.80
Total Equity
1,929.60
2,392.00
2,825.10
3,639.90
168.80
Liabilities & Shareholders' Equity
1,401.90
868.60
692.70
5,196.20
1,849.70
Non-Equity Reserves
-
-
3,323.60
-
-

About Avivagen

View Profile
Address
100 Sussex Drive
Ottawa Ontario K1A 0R6
Canada
Employees -
Website http://www.avivagen.com
Updated 07/08/2019
Avivagen, Inc. engages in the development and commercialization of products for livestock. Its products include OxC-beta Livestock, Vivamune Vital Health Chews and Oximunol Chewable Tablets. The company was founded by Janusz Daroszewsk and Graham W.